Induced Pluripotent Stem Cells: Progress and Future Perspectives in the Stem Cell World
سال
: 2012
چکیده: Pluripotent stem cells (PSCs) have the potential to differentiate into many cell types and therefore can be a
valuable source for cell therapy. Embryonic stem cells (ESCs), which are derived from the inner cell mass (ICM)
of the blastocyst, are representative of PSCs. However, use of these cells has some limitations, especially ethical
restrictions and immune response. As a result, researchers have been looking for other cell sources or strategies
to overcome these limitations. One kind of cellular reprogramming is the process of guiding mature cells into a
state of gene expression similar to PSCs. It has been demonstrated that somatic cells can be reprogrammed by
various methods, including somatic cell nuclear transfer (SCNT) and cell fusion with ESCs or treatment with
their extracts. This implies that some factors in oocytes and ESCs are able to initiate the reprogramming process.
Accordingly, induced pluripotent stem cells (iPSCs) have been derived from somatic cells by ectopic expression
of some transcription factors. This discovery has resulted in raising several important questions about the
mechanisms by which these factors influence the reprogramming and epigenetic status of the cells. iPSCs hold
great promise for regenerative medicine, developmental biology, and drug discovery because they circumvent
problems associated with both ethical issues and immunological rejection. Here we review the experiments
involved in the discovery of iPSCs, important factors in their reprogramming, and their future perspectives in
cell therapy.
valuable source for cell therapy. Embryonic stem cells (ESCs), which are derived from the inner cell mass (ICM)
of the blastocyst, are representative of PSCs. However, use of these cells has some limitations, especially ethical
restrictions and immune response. As a result, researchers have been looking for other cell sources or strategies
to overcome these limitations. One kind of cellular reprogramming is the process of guiding mature cells into a
state of gene expression similar to PSCs. It has been demonstrated that somatic cells can be reprogrammed by
various methods, including somatic cell nuclear transfer (SCNT) and cell fusion with ESCs or treatment with
their extracts. This implies that some factors in oocytes and ESCs are able to initiate the reprogramming process.
Accordingly, induced pluripotent stem cells (iPSCs) have been derived from somatic cells by ectopic expression
of some transcription factors. This discovery has resulted in raising several important questions about the
mechanisms by which these factors influence the reprogramming and epigenetic status of the cells. iPSCs hold
great promise for regenerative medicine, developmental biology, and drug discovery because they circumvent
problems associated with both ethical issues and immunological rejection. Here we review the experiments
involved in the discovery of iPSCs, important factors in their reprogramming, and their future perspectives in
cell therapy.
کلیدواژه(گان): reprogramming,induced pluripotent stem cells
کالکشن
:
-
آمار بازدید
Induced Pluripotent Stem Cells: Progress and Future Perspectives in the Stem Cell World
Show full item record
contributor author | حبیب رضانژاد بردجی | en |
contributor author | مریم مقدم متین | en |
contributor author | Habib Rezanejadbardeji | fa |
contributor author | Maryam Moghaddam Matin | fa |
date accessioned | 2020-06-06T13:11:13Z | |
date available | 2020-06-06T13:11:13Z | |
date issued | 2012 | |
identifier uri | http://libsearch.um.ac.ir:80/fum/handle/fum/3345077 | |
description abstract | Pluripotent stem cells (PSCs) have the potential to differentiate into many cell types and therefore can be a valuable source for cell therapy. Embryonic stem cells (ESCs), which are derived from the inner cell mass (ICM) of the blastocyst, are representative of PSCs. However, use of these cells has some limitations, especially ethical restrictions and immune response. As a result, researchers have been looking for other cell sources or strategies to overcome these limitations. One kind of cellular reprogramming is the process of guiding mature cells into a state of gene expression similar to PSCs. It has been demonstrated that somatic cells can be reprogrammed by various methods, including somatic cell nuclear transfer (SCNT) and cell fusion with ESCs or treatment with their extracts. This implies that some factors in oocytes and ESCs are able to initiate the reprogramming process. Accordingly, induced pluripotent stem cells (iPSCs) have been derived from somatic cells by ectopic expression of some transcription factors. This discovery has resulted in raising several important questions about the mechanisms by which these factors influence the reprogramming and epigenetic status of the cells. iPSCs hold great promise for regenerative medicine, developmental biology, and drug discovery because they circumvent problems associated with both ethical issues and immunological rejection. Here we review the experiments involved in the discovery of iPSCs, important factors in their reprogramming, and their future perspectives in cell therapy. | en |
language | English | |
title | Induced Pluripotent Stem Cells: Progress and Future Perspectives in the Stem Cell World | en |
type | Journal Paper | |
contenttype | External Fulltext | |
subject keywords | reprogramming | en |
subject keywords | induced pluripotent stem cells | en |
journal title | Cellular Reprogramming | fa |
pages | 459-470 | |
journal volume | 14 | |
journal issue | 6 | |
identifier link | https://profdoc.um.ac.ir/paper-abstract-1032270.html | |
identifier articleid | 1032270 |